Fatty acid 2-Hydroxylation in mammalian sphingolipid biology

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1801, Issue 4, 2010, Pages 405-414

  Hama, Hiroko ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

FA2H; Fatty acid 2 hydroxylase; Fatty acid alpha hydroxylase; Hydroxy fatty acid; Hydroxy sphingolipids

Indexed keywords

CERAMIDASE; HYDROXY FATTY ACID; LIPID; SPHINGOLIPID; SPHINGOLIPID ACTIVATOR PROTEIN;

BIOSYNTHESIS; CELL MEMBRANE PERMEABILITY; EPIDERMIS; HUMAN; HYDROLYSIS; HYDROXYLATION; LEUKODYSTROPHY; LIPOGENESIS; LYSOSOME; MAMMAL; MUTATION; NERVOUS SYSTEM; NONHUMAN; OXIDATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; REVIEW; SKIN; SPASTIC PARAPLEGIA; TISSUE DISTRIBUTION;

ANIMALS; FATTY ACIDS; HUMANS; HYDROXYLATION; MIXED FUNCTION OXYGENASES; SPHINGOLIPIDS;

MAMMALIA;

EID: 76549085920     PISSN: 13881981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbalip.2009.12.004     Document Type: Review

References (113)

1. Pruett S.T., Bushnev A., Hagedorn K., Adiga M., Haynes C.A., Sullards M.C., Liotta D.C., and Merrill Jr. A.H. Biodiversity of sphingoid bases ("sphingosines") and related amino alcohols. J. Lipid Res. 49 (2008) 1621-1639
2. Deuel H.J. Chemistry of the Phosphatides and Cerebrosides. In: Deuel H.J. (Ed). The Lipids, Their Chemistry and Biochemistry vol. 1 (1951), Interscience Publishers, New York, Chemistry 405-496
3. Kishimoto Y., and Radin N.S. Occurrence of 2-Hydroxy Fatty Acids in Animal Tissues. J. Lipid Res. 4 (1963) 139-143
4. Hoshi M., and Kishimoto Y. Synthesis of cerebronic acid from lignoceric acid by rat brain preparation. Some properties and distribution of the α-hydroxylation system. J. Biol. Chem. 248 (1973) 4123-4130
5. Akanuma H., and Kishimoto Y. Synthesis of ceramides and cerebrosides containing both alpha-hydroxy and nonhydroxy fatty acids from lignoceroyl-CoA by rat brain microsomes. J. Biol. Chem. 254 (1979) 1050-1060
6. Kishimoto Y., Akanuma H., and Singh I. Fatty acid alpha-hydroxylation and its relation to myelination. Mol. Cell. Biochem. 28 (1979) 93-105
7. Shigematsu H., Hisanari Y., and Kishimoto Y. Alpha-hydroxylation of lignoceroyl-CoA in rat brain microsomes: involvement of NADPH-cytochrome c reductase and topical distribution. Int. J. Biochem. 22 (1990) 1427-1432
8. Shigematsu H., and Kishimoto Y. Alpha-hydroxylation of lignoceroyl-CoA by a cyanide-sensitive oxygenase in rat brain microsomes. Int. J. Biochem. 19 (1987) 41-46
9. Alderson N.L., Rembiesa B.M., Walla M.D., Bielawska A., Bielawski J., and Hama H. The human FA2H gene encodes a fatty acid 2-hydroxylase. J. Biol. Chem. 279 (2004) 48562-48568
10. Eckhardt M., Yaghootfam A., Fewou S.N., Zoller I., and Gieselmann V. A mammalian fatty acid hydroxylase responsible for the formation of alpha-hydroxylated galactosylceramide in myelin. Biochem. J. 388 (2005) 245-254
11. Edvardson S., Hama H., Shaag A., Gomori J.M., Berger I., Soffer D., Korman S.H., Taustein I., Saada A., and Elpeleg O. Mutations in the fatty acid 2-hydroxylase gene are associated with leukodystrophy with spastic paraparesis and dystonia. Am. J. Hum. Genet. 83 (2008) 643-648
12. Shanklin J., and Cahoon E.B. Desaturation and related modifications of fatty acids. Annu. Rev. Plant Physiol. Plant Mol. Biol. 49 (1998) 611-641
13. Alderson N.L., Walla M.D., and Hama H. A novel method for the measurement of in vitro fatty acid 2-hydroxylase activity by gas chromatography-mass spectrometry. J. Lipid Res. 46 (2005) 1569-1575
14. Alderson N.L., Maldonado E.N., Kern M.J., Bhat N.R., and Hama H. FA2H-dependent fatty acid 2-hydroxylation in postnatal mouse brain. J. Lipid Res. 47 (2006) 2772-2780
15. Wanders R.J., Jansen G.A., and Lloyd M.D. Phytanic acid alpha-oxidation, new insights into an old problem: a review. Biochim. Biophys. Acta 1631 (2003) 119-135
16. Mukherji M., Kershaw N.J., Schofield C.J., Wierzbicki A.S., and Lloyd M.D. Utilization of sterol carrier protein-2 by phytanoyl-CoA 2-hydroxylase in the peroxisomal alpha oxidation of phytanic acid. Chem. Biol. 9 (2002) 597-605
17. Searls T., Butler D., Chien W., Mukherji M., Lloyd M.D., and Schofield C.J. Studies on the specificity of unprocessed and mature forms of phytanoyl-CoA 2-hydroxylase and mutation of the iron binding ligands. J. Lipid Res. 46 (2005) 1660-1667
18. Mizutani Y., Kihara A., Chiba H., Tojo H., and Igarashi Y. 2-Hydroxy-ceramide synthesis by ceramide synthase family: enzymatic basis for the preference of FA chain length. J. Lipid Res. 49 (2008) 2356-2364
19. Uchida Y., Hama H., Alderson N.L., Douangpanya S., Wang Y., Crumrine D.A., Elias P.M., and Holleran W.M. Fatty acid 2-hydroxylase, encoded by FA2H, accounts for differentiation-associated increase in 2-OH ceramides during keratinocyte differentiation. J. Biol. Chem. 282 (2007) 13211-13219
20. Dahiya R., and Brasitus T.A. Glycosphingolipids of fetal and adult sheep colonic mucosa. Lipids 20 (1985) 331-336
21. Dahiya R., and Brasitus T.A. Glycosphingolipid patterns of fetal and adult small intestinal mucosa in the sheep. Biochim. Biophys. Acta 875 (1986) 220-226
22. Dahiya R., Brown M.D., and Brasitus T.A. Distribution of glycosphingolipids of monkey small and large intestinal mucosa. Lipids 21 (1986) 107-111
23. Schaeren-Wiemers N., van der Bijl P., and Schwab M.E. The UDP-galactose:ceramide galactosyltransferase: expression pattern in oligodendrocytes and Schwann cells during myelination and substrate preference for hydroxyceramide. J. Neurochem. 65 (1995) 2267-2278
24. Futerman A.H., and van Meer G. The cell biology of lysosomal storage disorders. Nat. Rev. Mol. Cell Biol. 5 (2004) 554-565
25. Sugita M., Connolly P., Dulaney J.T., and Moser H.W. Fatty acid composition of free ceramides of kidney and cerebellum from a patient with Farber's disease. Lipids 8 (1973) 401-406
26. Sugita M., Iwamori M., Evans J., McCluer R.H., Dulaney J.T., and Moser H.W. High performance liquid chromatography of ceramides: application to analysis in human tissues and demonstration of ceramide excess in Farber's disease. J. Lipid Res. 15 (1974) 223-226
27. Matsuda J., Kido M., Tadano-Aritomi K., Ishizuka I., Tominaga K., Toida K., Takeda E., Suzuki K., and Kuroda Y. Mutation in saposin D domain of sphingolipid activator protein gene causes urinary system defects and cerebellar Purkinje cell degeneration with accumulation of hydroxy fatty acid-containing ceramide in mouse. Hum. Mol. Genet. 13 (2004) 2709-2723
28. Kolter T., and Sandhoff K. Principles of lysosomal membrane digestion: stimulation of sphingolipid degradation by sphingolipid activator proteins and anionic lysosomal lipids. Annu. Rev. Cell Dev. Biol. 21 (2005) 81-103
29. Kyogashima M., Tadano-Aritomi K., Aoyama T., Yusa A., Goto Y., Tamiya-Koizumi K., Ito H., Murate T., Kannagi R., and Hara A. Chemical and apoptotic properties of hydroxy-ceramides containing long-chain bases with unusual alkyl chain lengths. J. Biochem. 144 (2008) 95-106
30. Ji L., Zhang G., Uematsu S., Akahori Y., and Hirabayashi Y. Induction of apoptotic DNA fragmentation and cell death by natural ceramide. FEBS Lett. 358 (1995) 211-214
31. Foulon V., Sniekers M., Huysmans E., Asselberghs S., Mahieu V., Mannaerts G.P., Van Veldhoven P.P., and Casteels M. Breakdown of 2-hydroxylated straight chain fatty acids via peroxisomal 2-hydroxyphytanoyl-CoA lyase: a revised pathway for the alpha-oxidation of straight chain fatty acids. J. Biol. Chem. 280 (2005) 9802-9812
32. Kishimoto Y., and Radin N.S. Isolation and determination methods for brain cerebrosides, hydroxy fatty acids, and unsaturated and saturated fatty acids. J. Lipid Res. 1 (1959) 72-78
33. Kishimoto Y., and Radin N.S. Composition of cerebroside acids as a function of age. J. Lipid Res. 1 (1959) 79-82
34. Hajra A.K., and Norman S.R. Biosynthesis of the cerebroside odd-numbered fatty acids. J. Lipid Res. 3 (1962) 327-332
35. Mead J.F., and Levis G.M. A 1 carbon degradation of the long chain fatty acids of brain sphingolipids. J. Biol. Chem. 238 (1963) 1634-1636
36. Norton W.T., and Cammer W. Isolation and characterization of myelin. In: Morell P. (Ed). myelin (1984), Plenum, New York
37. Dick K.J., Al-Mjeni R., Baskir W., Koul R., Simpson M.A., Patton M.A., Raeburn S., and Crosby A.H. A novel locus for an autosomal recessive hereditary spastic paraplegia (SPG35) maps to 16q21-q23. Neurology 71 (2008) 248-252
38. Zoller I., Meixner M., Hartmann D., Bussow H., Meyer R., Gieselmann V., and Eckhardt M. Absence of 2-hydroxylated sphingolipids is compatible with normal neural development but causes late-onset axon and myelin sheath degeneration. J. Neurosci. 28 (2008) 9741-9754
39. Downing D.T. Lipid and protein structures in the permeability barrier of mammalian epidermis. J. Lipid Res. 33 (1992) 301-313
40. Feingold K.R. Thematic review series: skin lipids. The role of epidermal lipids in cutaneous permeability barrier homeostasis. J. Lipid Res. 48 (2007) 2531-2546
41. Holleran W.M., Takagi Y., and Uchida Y. Epidermal sphingolipids: metabolism, function, and roles in skin disorders. FEBS Lett. 580 (2006) 5456-5466
42. Makita A. Biochemistry of Organ Glycolipids. Ii. Isolation of Human Kidney Glycolipids. J. Biochem. 55 (1964) 269-276
43. Igisu H., and Suzuki K. Glycolipids of the spinal cord, sciatic nerve, and systemic organs of the twitcher mouse. J. Neuropathol. Exp. Neurol. 43 (1984) 22-36
44. Sprong H., Kruithof B., Leijendekker R., Slot J.W., van Meer G., and van der Sluijs P. UDP-galactose:ceramide galactosyltransferase is a class I integral membrane protein of the endoplasmic reticulum. J. Biol. Chem. 273 (1998) 25880-25888
45. Bouhours D., and Bouhours J.F. Developmental changes of hematoside of rat small intestine. Postnatal hydroxylation of fatty acids and sialic acid. J. Biol. Chem. 258 (1983) 299-304
46. Bouhours D., and Bouhours J.F. Developmental changes of monohexosylceramide and free ceramide in the large intestine of the rat. J. Biochem. 98 (1985) 1359-1366
47. Bouhours J.F., Bouhours D., and Hansson G.C. Developmental changes of glycosphingolipid composition of epithelia of rat digestive tract. Adv. Lipid Res. 26 (1993) 353-372
48. Riboni L., Acquotti D., Casellato R., Ghidoni R., Montagnolo G., Benevento A., Zecca L., Rubino F., and Sonnino S. Changes of the human liver GM3 ganglioside molecular species during aging. Eur. J. Biochem. 203 (1992) 107-113
49. Pascher I. Molecular arrangements in sphingolipids. Conformation and hydrogen bonding of ceramide and their implication on membrane stability and permeability. Biochim. Biophys. Acta 455 (1976) 433-451
50. Pascher I., and Sundell S. Molecular arrangements in sphingolipids. The crystal structure of cerebroside. Chem. Phys. Lipids 20 (1977) 175-191
51. Lofgren H., and Pascher I. Molecular arrangements of sphingolipids. The monolayer behavior of ceramides. Chem. Phys. Lipids 20 (1977) 273-284
52. Boggs J.M., Koshy K.M., and Rangaraj G. Influence of structural modifications on the phase behavior of semi- synthetic cerebroside sulfate. Biochim. Biophys. Acta 938 (1988) 361-372
53. Rapport M.M., and Graf L. Immunochemical reactions of lipids. Prog. Allergy 13 (1969) 273-331
54. Birkle S., Zeng G., Gao L., Yu R.K., and Aubry J. Role of tumor-associated gangliosides in cancer progression. Biochimie 85 (2003) 455-463
55. Hakomori S. Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism. Cancer Res. 56 (1996) 5309-5318
56. Kiguchi K., Takamatsu K., Tanaka J., Nozawa S., Iwamori M., and Nagai Y. Glycosphingolipids of various human ovarian tumors: a significantly high expression of I3SO3GalCer and Lewis antigen in mucinous cystadenocarcinoma. Cancer Res. 52 (1992) 416-421
57. Ladisch S., Sweeley C.C., Becker H., and Gage D. Aberrant fatty acyl alpha-hydroxylation in human neuroblastoma tumor gangliosides. J. Biol. Chem. 264 (1989) 12097-12105
58. Nilsson O., Brezicka F.T., Holmgren J., Sorenson S., Svennerholm L., Yngvason F., and Lindholm L. Detection of a ganglioside antigen associated with small cell lung carcinomas using monoclonal antibodies directed against fucosyl-GM1. Cancer Res. 46 (1986) 1403-1407
59. Hakomori S., Nudelman E., Levery S.B., and Kannagi R. Novel fucolipids accumulating in human adenocarcinoma. I. Glycolipids with di- or trifucosylated type 2 chain. J. Biol. Chem. 259 (1984) 4672-4680
60. Yang H.J., and Hakomori S.I. A sphingolipid having a novel type of ceramide and lacto-N-fucopentaose 3. J. Biol. Chem. 246 (1971) 1192-1200
61. Ugorski M., Pahlsson P., Dus D., Nilsson B., and Radzikowski C. Glycosphingolipids of human urothelial cell lines with different grades of transformation. Glycoconj. J. 6 (1989) 303-318
62. Iwamori M., Iwamori Y., Kubushiro K., Ishiwata I., and Kiguchi K. Characteristic expression of Lewis-antigenic glycolipids in human ovarian carcinoma-derived cells with anticancer drug-resistance. J. Biochem. 141 (2007) 309-317
63. Kiguchi K., Iwamori Y., Suzuki N., Kobayashi Y., Ishizuka B., Ishiwata I., Kita T., Kikuchi Y., and Iwamori M. Characteristic expression of globotriaosyl ceramide in human ovarian carcinoma-derived cells with anticancer drug resistance. Cancer Sci. 97 (2006) 1321-1326
64. Herrero A.B., Astudillo A.M., Balboa M.A., Cuevas C., Balsinde J., and Moreno S. Levels of SCS7/FA2H-mediated fatty acid 2-hydroxylation determine the sensitivity of cells to antitumor PM02734. Cancer Res. 68 (2008) 9779-9787
65. Hannun Y.A. Functions of ceramide in coordinating cellular responses to stress. Science 274 (1996) 1855-1859
66. Okazaki T., Bell R.M., and Hannun Y.A. Sphingomyelin turnover induced by vitamin D3 in HL-60 cells. Role in cell differentiation. J. Biol. Chem. 264 (1989) 19076-19080
67. Hannun Y.A., and Obeid L.M. Principles of bioactive lipid signalling: lessons from sphingolipids. Nat. Rev. Mol. Cell Biol. 9 (2008) 139-150
68. Alderson N.L., and Hama H. Fatty acid 2-hydroxylase regulates cAMP-induced cell cycle exit in D6P2T Schwannoma cells. J. Lipid Res. 50 (2009) 1203-1208
69. Clark R., Stewart M., Miskimins W.K., and Miskimins R. Involvement of MAP kinase in the cyclic AMP induction of myelin basic protein gene expression. Int. J. Dev. Neurosci. 16 (1998) 323-331
70. Friessen A.J., Miskimins W.K., and Miskimins R. Cyclin-dependent kinase inhibitor p27kip1 is expressed at high levels in cells that express a myelinating phenotype. J. Neurosci. Res. 50 (1997) 373-382
71. Atanasoski S., Boller D., De Ventura L., Koegel H., Boentert M., Young P., Werner S., and Suter U. Cell cycle inhibitors p21 and p16 are required for the regulation of Schwann cell proliferation. Glia 53 (2006) 147-157
72. Kannagi R., Stroup R., Cochran N.A., Urdal D.L., Young Jr. W.W., and Hakomori S. Factors affecting expression of glycolipid tumor antigens: influence of ceramide composition and coexisting glycolipid on the antigenicity of gangliotriaosylceramide in murine lymphoma cells. Cancer Res. 43 (1983) 4997-5005
73. Nakakuma H., Arai M., Kawaguchi T., Horikawa K., Hidaka M., Sakamoto K., Iwamori M., Nagai Y., and Takatsuki K. Monoclonal antibody to galactosylceramide: discrimination of structural difference in the ceramide moiety. FEBS Lett. 258 (1989) 230-232
74. Binnington B., Lingwood D., Nutikka A., and Lingwood C.A. Effect of globotriaosyl ceramide fatty acid alpha-hydroxylation on the binding by verotoxin 1 and verotoxin 2. Neurochem. Res. 27 (2002) 807-813
75. Angstrom J., Teneberg S., Milh M.A., Larsson T., Leonardsson I., Olsson B.M., Halvarsson M.O., Danielsson D., Naslund I., Ljungh A., Wadstrom T., and Karlsson K.A. The lactosylceramide binding specificity of Helicobacter pylori. Glycobiology 8 (1998) 297-309
76. Stromberg N., and Karlsson K.A. Characterization of the binding of propionibacterium granulosum to glycosphingolipids adsorbed on surfaces. An apparent recognition of lactose which is dependent on the ceramide structure. J. Biol. Chem. 265 (1990) 11244-11250
77. Stromberg N., and Karlsson K.A. Characterization of the binding of Actinomyces naeslundii (ATCC 12104) and Actinomyces viscosus (ATCC 19246) to glycosphingolipids, using a solid-phase overlay approach. J. Biol. Chem. 265 (1990) 11251-11258
78. Stromberg N., Ryd M., Lindberg A.A., and Karlsson K.A. Studies on the binding of bacteria to glycolipids. Two species of Propionibacterium apparently recognize separate epitopes on lactose of lactosylceramide. FEBS Lett. 232 (1988) 193-198
79. Tang W., Seino K., Ito M., Konishi T., Senda H., Makuuchi M., Kojima N., and Mizuochi T. Requirement of ceramide for adhesion of Helicobacter pylori to glycosphingolipids. FEBS Lett. 504 (2001) 31-35
80. Llado V., Gutierrez A., Martinez J., Casas J., Teres S., Higuera M., Galmes A., Saus C., Besalduch J., Busquets X., and Escriba P.V. Minerval Induces Apoptosis in Jurkat and Other Cancer Cells. J. Cell. Mol. Med. (2008)
81. Martinez J., Gutierrez A., Casas J., Llado V., Lopez-Bellan A., Besalduch J., Dopazo A., and Escriba P.V. The repression of E2F-1 is critical for the activity of Minerval against cancer. J. Pharmacol. Exp. Ther. 315 (2005) 466-474
82. Martinez J., Vogler O., Casas J., Barcelo F., Alemany R., Prades J., Nagy T., Baamonde C., Kasprzyk P.G., Teres S., Saus C., and Escriba P.V. Membrane structure modulation, protein kinase C alpha activation, and anticancer activity of minerval. Mol. Pharmacol. 67 (2005) 531-540
83. Llado V., Teres S., Higuera M., Alvarez R., Noguera-Salva M.A., Halver J.E., Escriba P.V., and Busquets X. Pivotal role of dihydrofolate reductase knockdown in the anticancer activity of 2-hydroxyoleic acid. Proc. Natl. Acad. Sci. U. S. A. 106 (2009) 13754-13758
84. Alemany R., Teres S., Baamonde C., Benet M., Vogler O., and Escriba P.V. 2-hydroxyoleic acid: a new hypotensive molecule. Hypertension 43 (2004) 249-254
85. Borchert G.H., Giggey M., Kolar F., Wong T.M., Backx P.H., and Escriba P.V. 2-hydroxyoleic acid affects cardiomyocyte [Ca2+]i transient and contractility in a region-dependent manner. Am. J. Physiol. Heart Circ. Physiol. 294 (2008) H1948-1955
86. Ahmed K., Tunaru S., Langhans C.D., Hanson J., Michalski C.W., Kolker S., Jones P.M., Okun J.G., and Offermanns S. Deorphanization of GPR109B as a receptor for the beta-oxidation intermediate 3-OH-octanoic acid and its role in the regulation of lipolysis. J. Biol. Chem. 284 (2009) 21928-21933
87. Bouhours J.F., and Bouhours D. Identification of free ceramide in human erythrocyte membrane. J. Lipid Res. 25 (1984) 613-619
88. Hara A., and Taketomi T. Long chain base and fatty acid compositions of equine kidney sphingolipids. J. Biochem. 78 (1975) 527-536
89. Bouhours J.F., and Guignard H. Free ceramide, sphingomyelin, and glucosylceramide of isolated rat intestinal cells. J. Lipid Res. 20 (1979) 879-907
90. Iwamori M., Costello C., and Moser H.W. Analysis and quantitation of free ceramide containing nonhydroxy and 2-hydroxy fatty acids, and phytosphingosine by high-performance liquid chromatography. J. Lipid Res. 20 (1979) 86-96
91. Yasugi E., Kasama T., and Seyama Y. Composition of long chain bases in ceramide of the guinea pig Harderian gland. J. Biochem. 110 (1991) 202-206
92. Karlsson K., Nilsson K., Samuelsson B.E., and Steen G.O. The presence of hydroxy fatty acids in sphingomyelins of bovine rennet stomach. Biochim. Biophys. Acta 176 (1969) 660-663
93. Breimer M.E. Distribution of molecular species of sphingomyelins in different parts of bovine digestive tract. J. Lipid Res. 16 (1975) 189-194
94. Breimer M.E., Karlsson K.A., and Samuelsson B.E. Presence of phytosphingosine combined with 2-hydroxy fatty acids in sphingomyelins of bovine kidney and intestinal mucosa. Lipids 10 (1975) 17-19
95. Morrison W.R., and Hay J.D. Polar lipids in bovine milk. II. Long-chain bases, normal and 2-hydroxy fatty acids, and isomeric cis and trans monoenoic fatty acids in the sphingolipids. Biochim. Biophys. Acta 202 (1970) 460-467
96. Yasugi E., Kasama T., Shibahara M., and Seyama Y. Composition of long-chain bases in sphingomyelin of the guinea pig Harderian gland. Biochem. Cell Biol. 68 (1990) 154-160
97. Robinson B.S., Johnson D.W., and Poulos A. Novel molecular species of sphingomyelin containing 2-hydroxylated polyenoic very-long-chain fatty acids in mammalian testes and spermatozoa. J. Biol. Chem. 267 (1992) 1746-1751
98. Nilsson O., and Svennerholm L. Characterization and quantitative determination of gangliosides and neutral glycosphingolipids in human liver. J. Lipid Res. 23 (1982) 327-334
99. Martensson E. Neutral glycolipids of human kidney isolation, identification, and fatty acid composition. Biochim. Biophys. Acta 116 (1966) 296-308
100. Breimer M.E., Hansson G.C., and Leffler H. The specific glycosphingolipid composition of human ureteral epithelial cells. J. Biochem. 98 (1985) 1169-1180
101. Mikami M., Tukazaki K., Nozawa S., Iwamori M., and Nagai Y. Menstrual cycle-associated expression of 2-hydroxy fatty acyl phytosphingosine-containing GlcCer, LacCer and Gb3Cer in human uterine endometrium. Biochim. Biophys. Acta 1125 (1992) 104-109
102. Karlsson K.A., Samuelsson B.E., and Steen G.O. Separation of monoglycosylceramides (cerebrosides) of bovine kidney into subgroups and characterization by mass spectrometry. Biochim. Biophys. Acta 306 (1973) 317-328
103. Bouhours D., and Bouhours J.F. Developmental changes of the lipidic part of the neutral glycosphingolipids of the rat stomach. J. Biol. Chem. 260 (1985) 2172-2177
104. Bouhours J.F., and Glickman R.M. Rat intestinal glycolipids. III. Fatty acids and long chain bases of glycolipids from villus and crypt cells. Biochim. Biophys. Acta 487 (1977) 51-60
105. Breimer M.E., Hansson G.C., Karlsson K.A., and Leffler H. Studies on differentiating epithelial cells of rat small intestine. Alterations in the lipophilic part of glycosphingolipids during cell migration from crypt villus tip. Biochim. Biophys. Acta 710 (1982) 415-427
106. Umesaki Y., Suzuki A., Kasama T., Tohyama K., Mutai M., and Yamakawa T. Presence of asialo GM1 and glucosylceramide in the intestinal mucosa of mice and induction of fucosyl asialo GM1 by conventionalization of germ-free mice. J. Biochem. 90 (1981) 1731-1738
107. Seyfried T.N., Ando S., and Yu R.K. Isolation and characterization of human liver hematoside. J. Lipid Res. 19 (1978) 538-543
108. Angstrom J., Breimer M.E., Falk K.E., Griph I., Hansson G.C., Karlsson K.A., and Leffler H. Separation and characterization of hematosides with different sialic acids and ceramides from rat small intestine. Different composition of epithelial cells versus non-epithelial tissue and of duodenum versus jejunum-ileum. J. Biochem. 90 (1981) 909-921
109. Bouhours D., and Bouhours J.F. Tissue-specific expression of GM3(NeuGc) and GD3(NeuGc) in epithelial cells of the small intestine of strains of inbred rats. Absence of NeuGc in intestine and presence in kidney gangliosides of brown Norway and spontaneously hypertensive rats. J. Biol. Chem. 263 (1988) 15540-15545
110. Rauvala H. Gangliosides of human kidney. J. Biol. Chem. 251 (1976) 7517-7520
111. Ito A., and Sato R. Proteolytic microdissection of smooth-surfaced vesicles of liver microsomes. J. Cell Biol. 40 (1969) 179-189
112. Dunn T.M., Haak D., Monaghan E., and Beeler T.J. Synthesis of monohydroxylated inositolphosphorylceramide (IPC-C) in Saccharomyces cerevisiae requires Scs7p, a protein with both a cytochrome b5-like domain and a hydroxylase/desaturase domain. Yeast 14 (1998) 311-321
113. Mitchell A.G., and Martin C.E. Fah1p, a Saccharomyces cerevisiae cytochrome b5 fusion protein, and its Arabidopsis thaliana homolog that lacks the cytochrome b5 domain both function in the alpha-hydroxylation of sphingolipid-associated very long chain fatty acids. J. Biol. Chem. 272 (1997) 28281-28288